In this episode of Life Sciences 360, we dive deep into the world of GLP-1 medications with Dr. Jonathan Kaplan. We discuss weight management, how these medications work, their impact beyond weight loss, and the ethical considerations surrounding their use. Dr. Kaplan shares his insights on the healthcare industry's evolving landscape, the economic implications, and why these medications are changing everything from cosmetic surgery to chronic disease management.

Chapters:

00:00 Introduction  
00:02 Dr. Jonathan Kaplan’s Background  
00:16 Overview of GLP-1 Medications  
00:25 The Significance of GLP-1s  
00:35 Future FDA Approvals  
00:51 Welcome to the Episode  
01:12 Meet Dr. Jonathan Kaplan  
01:19 Dr. Kaplan’s Journey into Weight Management  
02:09 Early Days Before the GLP-1 Hype  
02:30 Compounding Pharmacy and Medication Shortages  
03:17 Success of the Weight Management Program  
03:23 YouTube Subscriber Request  
04:17 GLP-1 Mechanisms Explained  
05:00 How GLP-1s Work in the Body  
05:51 Historical Timeline of GLP-1 Medications  
06:48 Semaglutide’s Evolution  
07:23 The Rise of Ozempic and Wegovy  
07:43 New Developments in Weight Management  
08:54 Accidental Discoveries and Hormones  
09:35 Significance of GLP-1 Discoveries  
10:02 Medication Approval and Insurance Hurdles  
10:43 Patient Expectations vs. Reality  
12:09 Misconceptions About Weight Loss  
12:51 Other Health Benefits Beyond Weight Loss  
14:10 The Complex Psychology of Weight Loss  
15:16 Importance of Diet and Exercise  
16:10 How to Get Access to These Medications  
18:02 Transparent Pricing Model  
20:19 Maintenance and Subscription Options  
22:04 Challenges with Insurance  
23:21 Insurance Pitfalls and Complications  
24:42 Speed of Access and Medication Availability  
25:41 Ethical Considerations in Prescribing GLP-1s  
27:28 Balancing Ethics and Accessibility  
29:35 Broader Impact on Public Health and Economics  
30:35 Transforming Healthcare Through Weight Management  
32:12 Future of GLP-1 Medications  
33:58 Changing Consumer Preferences and Food Labels  
35:51 Reflections on Dr. Kaplan’s Career  
37:06 Closing Remarks  
39:11 Key Takeaway on Safe Access  
41:03 Conclusion and Gratitude  

🔗 Links Mentioned:

Dr. Jonathan Kaplan, Founder and CEO at Build My Health

Linkedin -  (https://www.linkedin.com/in/buildmybod/)
- Visit Dr. Jonathan Kaplan’s website: (https://www.drwell.com)
- Website : (https://www.buildmybod.com/author/kaplan/)

- Follow Dr. Well on TikTok and Instagram: (https://www.tiktok.com/@drwellrx)

- Contact Dr. Jonathan Kaplan: [email protected]

- Follow Life Sciences 360 on LinkedIn 
(https://www.linkedin.com/company/life-sciences-360)

---

 Subscribe to our podcast for more on life sciences: 
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr


#GLP1 #WeightLoss #HealthCare #LifeSciences360 #DrJonathanKaplan #Ozempic #Wegovy #WeightManagement #HealthAndWellness #GLP1Medications #Type2Diabetes #ObesityTreatment #MedicalPodcast #HealthyLiving #Pharmaceuticals #Semaglutide #Medicine #SciencePodcast #MedicalResearch #PreventiveHealth

For transcripts, check out the podcast website - www.lifesciencespod.com